Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LRCX vs GSK✓SelectedUSD · GSKLRCX vs GSK performance historyLatest closeAs of-0.07%11/17
Stock and ETF performance explorer

LRCX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+198,782.8%
GSK return
+1,698.4%
Excess return
+197,084.5%
Maximum drawdown
-87.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-2.3%+2.3%+0.9%
7D-5.3%-3.0%-2.2%-4.1%
30D-20.2%+0.4%-20.5%-20.6%
3M-38.7%-1.2%-37.5%-39.2%
6M-25.9%+0.9%-26.8%-28.0%
YTD+23.4%+4.0%+19.5%+17.8%
1Y+43.5%+7.3%+36.2%+34.9%
3Y+208.4%+57.1%+151.4%+136.3%
5Y+251.5%+43.0%+208.5%+174.4%
10Y+2,218.9%+103.1%+2,115.9%+1,441.4%
All+198,782.8%+1,698.4%+197,084.5%+46,705.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling